Oxytocic Pharmaceuticals Market Overview with Demographic Data and Industry Growth Trends 2021-2027
Labor induction is strategy followed to invigorate uterine constrictions during or before labor induction which lead to normal/vaginal birth. Synthetic oxytocin is broadly utilized all through labor and post-partum care in obstetrics. Oxytocic pharmaceuticals are made artificially and go about as like endogenous oxytocin by contracting uterine muscles. The medications are controlled through intravenous infusion/Injection or intramuscular infusion.
The global oxytocic pharmaceuticals market’s Intravenous Injection/Infusion segment was worth US$ 52.6 million in 2019 and is projected to grow at a CAGR of 10.5 percent to US$ 117.2 million by 2027.
The global oxytocic pharmaceuticals market is projected to rise due to an increase in the number of preterm births. According to the March of Dimes 2019 report card, the United States’ preterm birth rate increased to 10.02 percent in 2018 from 9.63 percent in 2015.
Clinical trials to determine the effectiveness of oxytocic drugs are projected to increase, providing lucrative growth opportunities for market players. For example, Wake Forest University Health Sciences began a randomized study in October 2019 to see how intramuscular oxytocin affects pupil diameter and heart rate variability.
Side effects of oxytocic drugs include loss of appetite, vomiting, stomach pain, nausea, redness or irritation at the injection site and cramping all of which are likely to restrict market development.
In terms of volume, the Hospitals segment dominated the global oxytocic pharmaceuticals market in 2019, accounting for 60.1 percent of the market, led by maternity clinics. The rising occurrence of preterm births is one of the major factors contributing to the segment’s dominance.
In terms of value, the postpartum hemorrhage segment dominated the global oxytocic pharmaceuticals market in 2019, accounting for 76.5 percent of the market, followed by labor arrest and imminent abortion. During the forecast period, the segment is expected to expand due to an increase in the prevalence of postpartum hemorrhage.
During caesarean sections, doctors recommend IV bolus oxytocin. In Germany, bolus oxytocin administration is used during caesarean sections despite the fact that it has more side effects than IV infusion doses. However, in the United Kingdom, a sluggish infusion of 5-10IU is commonly used.
The demand is expected to expand due to an increase in hospitalisation for labor procedures. According to the National Health Commission, China’s hospital distribution rate has stayed above 99 percent for the past six years, with the percentage in rural areas increasing from 51.7 percent in 1996 to 99.8 percent in 2018.
In September 2019, Kabi Fresenius SwissBioSim, a Fresenius Kabi subsidiary, has opened a new biosimilars research and development centre in Eysins, Switzerland.
In October 2019, Granules India Limited has declared that it will sell its entire equity shareholding in Granules Biocause Pharmaceuticals Co. Ltd. to Hubei Biocause Heilen Pharmaceutical Co. Ltd., a joint venture partner.
Purchase this Report at Discount Of US $2000 Flat OFF – https://www.coherentmarketinsights.com/promo/buynow/3354
Oxytocic Pharmaceuticals Market – Competitive Landscape
Key players functioning in the global prosthetic liners market consists of Fresenius Kabi AG, Biofutura SpA, Baxter Healthcare Corporation, Pfizer Inc., Ferring B.V., Novartis AG, and Teva Pharmaceutical Industries Ltd.
Main points in Oxytocic Pharmaceuticals Market Report Table of Content
Chapter 1 Industry Overview
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Global Oxytocic Pharmaceuticals Market Size Analysis from 2021 to 2027
11.6 COVID-19 Outbreak: Oxytocic Pharmaceuticals Industry Impact
Chapter 2 Global Oxytocic Pharmaceuticals Competition by Types, Applications, and Top Regions and Countries
2.1 Global Oxytocic Pharmaceuticals (Volume and Value) by Type
2.3 Global Oxytocic Pharmaceuticals (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Global Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Global Oxytocic Pharmaceuticals Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Oxytocic Pharmaceuticals Market Analysis
Chapter 6 East Asia Oxytocic Pharmaceuticals Market Analysis
Chapter 7 Europe Oxytocic Pharmaceuticals Market Analysis
Chapter 8 South Asia Oxytocic Pharmaceuticals Market Analysis
Chapter 9 Southeast Asia Oxytocic Pharmaceuticals Market Analysis
Chapter 10 Middle East Oxytocic Pharmaceuticals Market Analysis
Chapter 11 Africa Oxytocic Pharmaceuticals Market Analysis
Chapter 12 Oceania Oxytocic Pharmaceuticals Market Analysis
Chapter 13 South America Oxytocic Pharmaceuticals Market Analysis
Chapter 14 Company Profiles and Key Figures in Oxytocic Pharmaceuticals Business
Chapter 15 Global Oxytocic Pharmaceuticals Market Forecast (2021-2027)
Chapter 16 Conclusions
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Phone: US +12067016702 / UK +4402081334027
- CDN Newswire